NCT07633730Recruiting
Efficacy of the Erector Spinae Plane Block for Persistent Back Pain in Patients With Ankylosing Spondylitis
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
Despite adequate control of disease activity with standard medical therapies, there remains an ongoing need for complementary and interventional approaches for the management of persistent back pain in patients with ankylosing spondylitis. Although the erector spinae plane block has been described in the literature as a safe and effective analgesic intervention for chronic back pain in various patient populations, to the best of our knowledge, no clinical study has specifically evaluated its use for persistent back pain in patients with ankylosing spondylitis receiving medical treatment. Therefore, the present study aims to evaluate the effects of erector spinae plane block on pain severity and clinical outcomes in patients with ankylosing spondylitis whose disease activity is controlled under treatment but who continue to experience persistent back pain.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 2 Jun 2026
- Start date
- Jun 2026
- Primary completion date
- May 2027
- Lead sponsor
- Marmara University
- Diseases
- Ankylosing spondylitis
- NCT number
- NCT07633730
What you commit to
- Study type: Interventional
- Planned participants: 15
- From Jun 2026 to the primary completion date, May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of thoracic surgery
- Presence of major psychiatric comorbidity
- History of bleeding diathesis
- Presence of active local and/or systemic infection
- Known allergy to the medications to be injected
- Active phase of the disease (elevated acute phase reactants, active arthritis findings, etc.)
Other
- Body mass index (BMI) greater than 35 kg/m²
- Intellectual disability or mental retardation
- Congenital spinal anomaly
- Pregnancy
- Hemodynamic instability
Who the study is looking for
- Age between 18 and 65 years
- Diagnosis of ankylosing spondylitis according to the Modified New York Criteria
- Patients receiving ongoing treatment with controlled disease activity but persistent back pain
- Willingness to participate in the study
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Marmara University Faculty of Medicine Pendik Training and Research Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.